Bartholin's gland adenomyoma is a rare, noncancerous growth that forms near the vaginal opening where the Bartholin’s glands sit. People with Bartholin's gland adenomyoma may notice a small, firm lump, mild discomfort with sitting or sex, or pressure in the vulvar area. It usually grows slowly and symptoms can persist over months to years if untreated. Adults of reproductive age are most often affected, and not everyone will have the same experience. Treatment is typically minor surgery to remove the mass, and mortality is not expected with Bartholin's gland adenomyoma since it is benign.
Overview
Bartholin's gland adenomyomaSymptoms
Bartholin's gland adenomyoma usually shows up as a firm lump or swelling on one side of the vaginal opening. People may notice pressure, tenderness, or pain with sitting, walking, or sex; early symptoms can mimic a Bartholin’s cyst.
Outlook and prognosis
Most Bartholin’s gland adenomyomas are benign, grow slowly, and stay localized. After complete surgical removal, symptoms usually resolve and the chance of return is low, though follow-up helps catch rare recurrences. Long-term outlook for comfort, sexual function, and fertility is generally good.
Causes and risk factors
The exact cause is unknown; Bartholin's gland adenomyoma appears to arise sporadically and isn’t known to be inherited. No clear lifestyle or environmental risks are established. Reported cases mostly involve adults, suggesting age-related or hormonal influences, but data are limited.
Genetic influences
Genetics appears to play a minimal role in Bartholin’s gland adenomyoma. Most cases seem sporadic, likely linked to local tissue changes rather than inherited variants. Routine genetic testing isn’t recommended unless features suggest a different, hereditary condition.
Diagnosis
Diagnosis of Bartholin's gland adenomyoma begins with a pelvic exam of a vulvar mass. Ultrasound or MRI can define the lesion, but confirmation is by pathology after biopsy or excision, often to rule out cancer in those over 40.
Treatment and drugs
Treatment for Bartholin's gland adenomyoma is usually surgical removal of the lump, aiming to relieve pressure, pain, or discomfort with sitting, walking, or sex. Pathology review confirms the diagnosis. Follow‑up checks monitor healing and watch for rare recurrence.
Symptoms
Many people first notice a small, one-sided lump near the vaginal opening that rubs on clothing or makes biking uncomfortable. Early symptoms of Bartholin's gland adenomyoma are usually local, like pressure, tenderness, or a sense of fullness that can come and go. Symptoms vary from person to person and can change over time. Some have no symptoms at all and learn about it during a routine pelvic exam.
A small, one-sided lump or fullness near the vaginal opening is the most common sign. In Bartholin's gland adenomyoma, the lump tends to grow slowly on one side. It can be painless or mildly tender.
The area may feel sore to touch or after long periods of sitting, walking, or cycling. Tight clothing or wiping can make it more uncomfortable.
Penetration or certain positions can press on the lump and cause sharp or aching pain. Some people with Bartholin's gland adenomyoma shorten or avoid intercourse because of the discomfort.
A feeling that something is in the way at the vaginal opening can be noticeable. You might notice difficulty inserting a tampon or during pelvic exams.
How people usually first notice Bartholin's gland adenomyoma?
People usually first notice Bartholin’s gland adenomyoma as a painless or mildly tender lump near the vaginal opening, often on one side, that slowly enlarges over weeks to months and may feel firm compared with a typical cyst. It’s often mistaken for a Bartholin’s cyst or abscess at first, and many seek care when the mass starts causing discomfort with sitting, walking, or sex, or if it doesn’t go away after warm baths or drainage. Doctors typically suspect it during a pelvic exam when a persistent, solid-feeling mass is found in the Bartholin’s area, with confirmation coming after surgical removal and pathology.
Types of Bartholin's gland adenomyoma
Bartholin's gland adenomyoma is rare, and most reports describe a single clinicopathologic entity rather than multiple clear-cut subtypes. Clinicians often describe them in these categories: how the mass behaves (slow-growing vs. recurrent), where it sits in relation to the Bartholin’s gland or duct, and whether it causes symptoms like pain or pressure. People may notice different sets of symptoms depending on their situation. When reading about types of Bartholin’s gland adenomyoma, you’ll mostly see practical groupings based on location and behavior rather than distinct genetic variants.
Gland-centered mass
The growth arises within the Bartholin’s gland itself. It often feels like a firm lump deep in the lower vaginal opening on one side and may cause discomfort with sitting or sex. Early symptoms of Bartholin’s gland adenomyoma can be subtle and mimic a typical cyst.
Duct-involved lesion
The mass is closer to or involves the gland’s duct. This can lead to a feeling of fullness or a recurrent “cyst-like” swelling that drains and returns. Some notice pain that flares with activity or during periods of inflammation.
Recurrent pattern
The lesion returns after drainage or partial removal. People with this pattern may experience on‑and‑off swelling, pressure, or pain over months. Complete surgical excision usually lowers the chance of future episodes.
Asymptomatic finding
The adenomyoma is found incidentally during an exam or imaging. There may be no pain, and the only sign is a small, well-circumscribed lump. Many learn about it after evaluation for a suspected Bartholin’s cyst or abscess.
What genetics can tell you about symptoms
Some genetic changes that drive smooth muscle growth, like mutations affecting the MED12 gene pathway seen in other uterine-like tumors, may also be linked to Bartholin’s gland adenomyoma, leading to a firm, painless mass near the vaginal opening. When these pathways are overactive, cells multiply and form a benign tumor that can cause pressure, discomfort with sitting, or pain during sex.
Causes and risk factors
Bartholin's gland adenomyoma likely reflects a benign overgrowth in the Bartholin area, and the exact cause is still unknown. Some cases appear after long-standing gland blockage or past cysts, suggesting chronic irritation may play a role. Hormonal shifts during pregnancy or around menopause may influence growth, but strong evidence is limited. There are no known inherited genetic risks, and lifestyle factors have no proven link or ability to predict early symptoms of Bartholin's gland adenomyoma. Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
Bartholin's gland adenomyoma is uncommon, and clear risk factors are not firmly established. What follows are patterns clinicians notice in case descriptions, not guarantees that a lesion will form. Researchers are still exploring how outside influences interact with our inner biology. These risks do not predict early symptoms of Bartholin's gland adenomyoma, which can vary from person to person.
Many reports involve people in midlife. Age-related tissue remodeling may increase susceptibility. Cases can occur outside this age range.
Recurrent Bartholin’s cysts or abscesses can leave scarring and block the duct. These healing changes may encourage a benign gland-and-muscle overgrowth like Bartholin's gland adenomyoma. Evidence remains limited.
Local procedures or childbirth-related tears can trigger cycles of injury and healing. Repeated repair may promote smooth muscle overgrowth around glands. Not everyone with prior injury develops this lesion.
Benign overgrowths in reproductive tissues often respond to estrogen and progesterone. Hormonal shifts across the lifespan may nudge growth in susceptible tissue. This link is not confirmed in every case.
Genetic risk factors
Bartholin's gland adenomyoma is considered a benign, localized growth, and genetics has not been shown to play a major role. Published research is limited, and genetic risk factors for Bartholin's gland adenomyoma are not well defined. Science continues to uncover how these elements interact, but there is currently no clear hereditary pattern or recurrent gene change tied to this tumor. Most cases appear to occur at random rather than being passed down in families.
No inherited pattern: There is no evidence that this tumor runs in families or follows a predictable hereditary pattern. Known inherited cancer syndromes have not been linked to Bartholin’s gland adenomyoma.
Sporadic cell changes: When genetics are involved, they are usually acquired changes in the gland’s cells (called somatic changes), not changes you are born with. These are one-off events in the tumor and are not passed to children.
No known gene: Studies have not identified a recurring gene mutation or pathway that drives this condition. Genetic testing is not routinely recommended for diagnosis or risk assessment.
Data limited by rarity: Because this tumor is very rare, few samples have been deeply analyzed for genetic changes. As a result, any specific gene associations remain unconfirmed.
Lifestyle risk factors
Evidence for lifestyle risk factors for Bartholin's gland adenomyoma is limited, but certain habits can influence symptom burden, detection, and recovery. When discussing lifestyle risk factors for Bartholin's gland adenomyoma, focus is on behaviors that may worsen local irritation, infection risk, or healing if surgery is required. These factors do not cause the tumor, but they can affect how it feels, how quickly it’s recognized, and outcomes after treatment.
Unprotected sex and multiple partners can raise the risk of Bartholin gland infections, which may cause chronic duct changes and delay recognition of an adenomyoma. Safer sex practices may reduce infections and symptom flares around the gland.
Douching and fragranced washes can irritate the vulvar ducts and worsen swelling or pain near an adenomyoma. Gentle, non-fragranced cleansing can help limit irritation-related discomfort.
Long periods of pressure from sitting or cycling can exacerbate pain and swelling in the Bartholin region. Standing breaks, cushioned seats, and looser clothing may lessen local symptoms.
Smoking impairs blood flow and wound healing after vulvar procedures, increasing risks if an adenomyoma is surgically removed. Quitting can improve healing and reduce postoperative complications.
Risk prevention
Bartholin's gland adenomyoma has no known single cause, and there isn’t a proven way to fully prevent it. Focus on noticing changes and getting timely evaluation; earlier care can ease symptoms and rule out other issues. Prevention is about lowering risk, not eliminating it completely. Safer sex and gentle vulvar care may reduce irritation and infections that can complicate the picture.
Regular check-ups can catch new vulvar or vaginal lumps early. Share any changes in the Bartholin area, including swelling, pressure, or discomfort.
If a lump near the vaginal opening lasts more than 2–4 weeks or grows, get it assessed. Early evaluation helps distinguish Bartholin's gland adenomyoma from cysts or infections.
Use condoms or dental dams to lower sexually transmitted infections that can inflame the Bartholin glands. Less inflammation means fewer confusing symptoms and easier diagnosis.
Use mild, unscented products and avoid harsh scrubs or tight, chafing clothing. Reducing irritation around the Bartholin glands may lower flare-ups and discomfort.
Transmission
Bartholin's gland adenomyoma is a benign growth, not an infection, so it isn’t contagious. It can’t be passed to a partner through sex or everyday contact.
There is no genetic transmission of Bartholin's gland adenomyoma, and it doesn’t typically run in families. It develops from local tissue overgrowth in the Bartholin’s gland rather than something you can catch or spread.
When to test your genes
Bartholin’s gland adenomyoma is not inherited, so routine genetic testing isn’t needed. Consider genetic testing only if there’s a strong family history of multiple gynecologic cancers or a known hereditary cancer syndrome. In those cases, results can guide screening schedules and surgical planning tailored to you.
Diagnosis
Bartholin's gland adenomyoma is usually found when a tender lump or pressure near the vaginal opening starts to interfere with sitting, walking, or intimacy. Doctors usually begin with questions about your symptoms and a careful exam, then add tests if needed. Imaging can help map the lump, but a tissue sample is what confirms the cause. The diagnosis of Bartholin's gland adenomyoma is typically made after removing or sampling the mass and reviewing it under a microscope.
Your provider asks when the lump started, whether it changes with your cycle, and if there is pain, drainage, or fever. These details help separate a benign growth from a cyst or infection.
A careful look and gentle exam of the vulva and vaginal opening help define the size, firmness, and location of the mass. Findings guide whether imaging or a biopsy comes next.
Swabs or simple lab tests may check for bacteria if there is redness, warmth, or drainage. This helps distinguish an abscess or infected cyst from a solid growth.
Pelvic or vulvar ultrasound uses sound waves to see if the lump is fluid-filled or solid. This noninvasive test helps plan treatment and decide whether a biopsy is needed.
Stages of Bartholin's gland adenomyoma
Bartholin's gland adenomyoma does not have defined progression stages. It is a rare, noncancerous growth that usually stays localized in the Bartholin’s area, so it doesn’t follow a predictable pattern of spread or stepwise decline. Early symptoms of Bartholin's gland adenomyoma may include a painless or tender lump near the vaginal opening, discomfort with sitting, walking, or sex, or a feeling of fullness that comes and goes. Evaluation typically includes a pelvic exam; Different tests may be suggested to help confirm the diagnosis, such as ultrasound or MRI, but a biopsy or surgical removal examined under the microscope provides a clear answer.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially after hearing a rare diagnosis like Bartholin’s gland adenomyoma. This benign growth usually stays localized, grows slowly, and does not spread to other parts of the body. Most people do well after a simple surgical removal, such as excision or marsupialization if a cyst-like component is present. Recurrence is uncommon, but it can happen if a small portion of the lesion remains; if that occurs, a second, more complete removal typically solves the problem.
Doctors call this the prognosis—a medical word for likely outcomes. There is no evidence that Bartholin’s gland adenomyoma shortens life expectancy, and deaths from this condition are not reported in the medical literature. Early symptoms of Bartholin’s gland adenomyoma, like a painless lump near the vaginal opening, pressure with sitting, or discomfort during sex, often improve quickly once the lesion is treated. Infections can happen if the duct is blocked, but targeted antibiotics and drainage, when needed, usually work well and do not change the long-term outlook.
Looking at the long-term picture can be helpful. Most people return to normal activities within days to weeks after minor surgery, with low risk of long-term problems. Follow-up is straightforward: a routine check to be sure healing is complete and no new lump appears. Talk with your doctor about what your personal outlook might look like, including the best procedure for you, ways to lower the chance of recurrence, and when to seek care if a new swelling or pain develops.
Long-term effects
For most people, this rare benign growth stays localized and is curable with surgery. Long-term effects vary widely, and many notice no ongoing problems after removal. Early symptoms of Bartholin's gland adenomyoma—like a small, painless lump or a feeling of pressure—often ease once the mass is taken out. Lasting issues, when they occur, usually relate to scarring or changes in lubrication rather than the tumor itself.
A sense of fullness, tenderness, or pressure in the vulva can persist until the growth is removed. After surgery, most people no longer feel a lump or ongoing soreness.
Pain with sex may happen before treatment due to pressure on nearby tissue. Most people find sexual comfort improves after removal, though a few have lingering sensitivity as the area heals.
Once fully excised, the tumor rarely comes back. If it does recur, repeat surgery is usually effective.
Removing one Bartholin’s gland can slightly reduce natural lubrication on that side. Many notice little to no change because other glands and tissues compensate.
How is it to live with Bartholin's gland adenomyoma?
Living with Bartholin’s gland adenomyoma often centers on managing pelvic discomfort or a palpable vulvar mass that can make sitting, cycling, or sexual activity uncomfortable, and flare-ups may add worry about infection or recurrence. Many find that planning for gentle movement, using warm compresses, and choosing comfortable clothing helps daily routines feel easier, and symptoms usually improve after appropriate treatment. Partners and close family may notice changes in intimacy or mood during painful periods, so open communication and patience can reduce strain and keep connection strong. Most people do well long term once the diagnosis is clear and care is tailored, which can be reassuring when symptoms have been confusing or persistent.
Treatment and drugs
Bartholin's gland adenomyoma is usually treated with a small surgical procedure, because medicines alone don’t reliably make the mass go away. The most common approach is complete excision of the lump under local or general anesthesia, which both confirms the diagnosis and removes the growth; recovery typically takes a few days to a couple of weeks. If the mass is cyst‑like or causing blockage, the surgeon may create a new drainage opening (marsupialization), but for a solid adenomyoma, full removal is preferred to reduce the chance of it coming back. Pain is managed with simple pain relievers such as acetaminophen or ibuprofen, and antibiotics are used only if there are signs of infection. Your doctor may suggest follow-up visits to check healing and make sure symptoms don’t return; finding the right therapy can take some time if there are repeat swellings or prior scarring.
Non-drug treatment
Bartholin's gland adenomyoma is uncommon, and non-drug care focuses on comfort, function, and planning the right procedure if needed. Beyond prescriptions, supportive therapies can ease pain, protect sexual health, and help daily routines feel normal again. Many options are simple and low risk, while surgery is often the definitive step when a lump causes symptoms or uncertainty. Your care team may combine several approaches based on your goals and exam findings.
If the Bartholin's gland adenomyoma is small and not bothersome, your team may monitor it with regular check-ins. This can avoid procedures until there’s a clear reason to act.
Warm shallow baths can reduce tenderness at the vulva and ease pressure when sitting or walking. Some people find this especially helpful after activity or intercourse.
A pelvic health physiotherapist can treat muscle guarding and pelvic pain linked to the lump. Techniques may improve comfort with sitting, exercise, and sex.
Outpatient excision can both confirm the diagnosis and relieve symptoms from Bartholin's gland adenomyoma. Pathology review of the tissue helps rule out other causes.
Your genes may have an impact on how drugs work for you
Some medicines for Bartholin’s gland adenomyoma can work differently from person to person because genes affect how fast the body absorbs, breaks down, and clears drugs. Pharmacogenetic testing sometimes helps guide pain control, hormone-related options, and safe dosing to reduce side effects.
Pharmacological treatments
Medicines for Bartholin's gland adenomyoma mainly support comfort and reduce complications around a planned procedure, since the core treatment is usually surgical removal. Drugs that target symptoms directly are called symptomatic treatments. They can ease early symptoms of Bartholin's gland adenomyoma such as localized pain, swelling, or pressure, and help recovery after surgery. Antibiotics are used only if there’s clear evidence of infection or an abscess at the gland.
Ibuprofen or naproxen can reduce pain and swelling, while acetaminophen can be used if anti-inflammatories aren’t suitable. These can be used short term before and after surgery to keep you comfortable. Not everyone responds to the same medication in the same way.
Lidocaine gel or a small lidocaine injection can numb the area for in-office procedures or to ease exam-related discomfort. This helps with brief but intense pain during drainage or excision steps.
Amoxicillin–clavulanate or doxycycline plus metronidazole may be prescribed if there’s cellulitis or an abscess at the Bartholin area. Clindamycin is an option if you’re allergic to penicillin. Doctors adjust treatment plans regularly based on symptoms and culture results.
For severe pain not controlled by NSAIDs or acetaminophen, a brief course of tramadol or oxycodone may be used. These are reserved for short periods because of side effects like constipation and sleepiness. Ask your doctor why a specific drug was recommended for you.
Genetic influences
Based on what’s known, there’s no clear evidence that Bartholin's gland adenomyoma is inherited or tied to a broader inherited condition. It’s natural to ask whether family history plays a role. Most cases are sporadic, meaning they arise in one person without a pattern among relatives; in other words, the condition does not seem to run in families, and current data do not suggest that Bartholin's gland adenomyoma is hereditary. When gene changes are found, they appear limited to the cells in the growth itself and are not the kind you’re born with or pass on to children. Because of this, routine genetic testing isn’t usually part of care; the focus is on diagnosing and treating the mass and ruling out other conditions that can look similar. If several relatives have had similar gynecologic tumors at a young age, share that history with your doctor so you can decide together whether a genetic counseling visit or broader evaluation could be helpful.
Is Bartholin's gland adenomyoma genetic?
Genetics appears to play a minimal role in Bartholin’s gland adenomyoma. Most cases seem sporadic, likely linked to local tissue changes rather than inherited variants. Routine genetic testing isn’t recommended unless features suggest a different, hereditary condition.
Pharmacogenetics—how genetics influence drug effects
Care for Bartholin's gland adenomyoma is usually procedural—drainage or surgical removal—so genes don’t currently direct the tumor treatment itself. That said, your genes can affect how you process medicines given around the procedure, especially pain relievers and some anesthetics. After surgery, one person may get solid relief from codeine, while another feels very sleepy yet still sore; this can relate to how quickly a liver enzyme turns the drug into its active form. People with very slow or very fast activity of a common enzyme (often called CYP2D6) may have either poor pain control or more side effects with codeine or tramadol, so a different pain plan may be safer. Rarely, an inherited enzyme issue can make certain muscle relaxants used during anesthesia last longer than expected, so it helps to mention any family history of prolonged waking after surgery. Genetic testing can sometimes identify how your body handles particular pain medicines, which may guide choices if you’ve had unusual reactions or need longer-term pain control. Even then, genes are just one part of dosing decisions—age, other medicines, and liver or kidney health matter too—so your team will tailor medication choices for Bartholin's gland adenomyoma to keep you comfortable and safe.
Interactions with other conditions
People with Bartholin's gland adenomyoma may also have Bartholin duct cysts or past abscesses, because a growth in this area can narrow the duct and make blockage or infection more likely. If a vaginal or skin infection is active, swelling and pain can be worse, and doctors may treat the infection first before planning a procedure. Doctors call it a “comorbidity” when two conditions occur together. Other vulvar conditions—like chronic skin irritation, eczema, or lichen sclerosus—can add soreness and make recovery after surgery slower, so care teams often tailor wound care and pain control.
There’s no clear link between Bartholin's gland adenomyoma and HPV-related disease, diabetes, or a higher cancer risk, but a lab review of the removed tissue is still important to rule out rare malignant tumors. Hormonal shifts (such as pregnancy, menopause, or certain hormone therapies) may change local discomfort or fullness for some, though firm data specific to Bartholin's gland adenomyoma are limited. If you’re on blood thinners or have bleeding disorders, your team will plan around a higher chance of bruising or bleeding with procedures. If early symptoms of Bartholin's gland adenomyoma show up at the same time as a vaginal infection or STI, treating the infection first often clarifies what symptoms belong to which condition.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden, tender swellings near the vaginal opening that made walking or sitting uncomfortable. Midwives wrote about “blocked glands” that sometimes eased with warm compresses, while surgeons later noted that some growths felt unusually firm and didn’t drain like a typical cyst. These everyday observations set the stage for recognizing that not every lump in this area behaved the same way.
First described in the medical literature as uncommon nodules of the Bartholin’s gland, these growths were initially grouped with cysts, abscesses, or general “adenomas.” Over time, careful pathology—looking at tissue under a microscope—showed that a small subset had both gland-like and smooth muscle features. As medical science evolved, pathologists began using the term Bartholin’s gland adenomyoma to mark this mixed pattern and to separate it from true tumors and infections.
From early reports to modern case series, clinicians noticed that most people with Bartholin’s gland adenomyoma reported a slow-growing, painless or mildly tender mass, often on one side, sometimes mistaken for a recurrent cyst. Surgeons observed that these lesions tended to be well-circumscribed and less likely to come back after complete removal than inflamed cysts that had only been drained. Not every early description was complete, yet together they built the foundation of today’s knowledge.
With the rise of imaging and better pathology techniques in the late 20th century, small details became clearer. Ultrasound and MRI could suggest a solid, well-defined mass rather than a fluid-filled sac, and special stains in the lab confirmed the dual nature of the tissue. This helped distinguish Bartholin’s gland adenomyoma from conditions that require different care, including abscesses that need drainage and rare cancers that call for wider surgery.
In recent decades, awareness has grown that Bartholin’s gland adenomyoma is a benign condition, usually managed by surgical excision if it causes symptoms. Case reports from different countries—often involving people in midlife—have reinforced that it is uncommon and typically found on routine exams or when a “cyst” doesn’t behave as expected. These historical steps improved counseling: most people can be reassured about the low risk of recurrence once the lesion is fully removed.
Today’s approach reflects this history. Clinicians still listen to the story—how the swelling started, whether pain flares with sitting or activity—then match it with exam findings and, when needed, imaging and pathology. Knowing the condition’s history helps explain why a persistent “cyst” may be sent for full removal and lab review: it ensures the correct name, Bartholin’s gland adenomyoma, and the right level of follow-up without over-treatment.